Immune Regulation

CellR4 2022; 10: e3330
DOI: 10.32113/cellr4_202210_3330

Corrigendum – Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

Alibashe-Ahmed M.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Berney T.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Giovannoni L.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Berishvili E.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
Eberishvili@gmail.com

CellR4 2022; 10: e3289
DOI: 10.32113/cellr4_20223_3289

Decreased Treg/Th17 ratio in Bulgarian patients after liver transplantation: a single-center experience

Mihova A. S.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
, Peruhova M. M.
Clinic of Gastroenterology, University Hospital Lozenets, Sofia, Bulgaria
, Kukov A. D.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
, Sekulovska-Peshevska M.
Clinic of Gastroenterology, University Hospital Lozenets, Sofia, Bulgaria
, Yurukova N. N.
Clinic of Gastroenterology, University Hospital Lozenets, Sofia, Bulgaria
, Ivanova I. L.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
, Stancheva A. G.
Clinical Laboratory, University Hospital Lozenets, Sofia, Bulgaria
, Velikova T. V.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
tsvelikova@medfac.mu-sofia.bg
, Altankova I. P.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria

CellR4 2021; 9: e3132
DOI: 10.32113/cellr4_20214_3132

Safety and efficacy of systemically administered autologous Gold-Induced Cytokines (GOLDIC®)

Schneider U.
iRegMed Tegernsee, Center for Regenerative Medicine, Gmund am Tegernsee, Germany
uschneider@iregmed.de
, Lotzof K.
Spire Bushey Hospital, London, UK
, Murrell W. D.
Abu Dhabi Knee and Sports Medicine, Healthpoint Hospital, Zayed Sports City, Abu Dhabi, United Arab Emirates
, Goetz von Wachter E.
iRegMed Tegernsee, Center for Regenerative Medicine, Gmund am Tegernsee, Germany
, Hollands P.
Freelance Consultant Clinical Scientist, Cambridge, UK

CellR4 2021; 9: e3058
DOI: 10.32113/cellr4_20212_3058

The role of Th17 cells in SARS-CoV-2 infection: implementation for the therapy of severe COVID-19 cases

Velikova T. V.
Department of Clinical Immunology, University Hospital Lozenetz, Sofia University St. Kliment Ohridski, Sofia, Bulgaria
tsvelikova@medfac.mu-sofia.bg
, Kotsev S. V.
Department of Infectious Diseases, Pazardzhik Multiprofile Hospital for Active Treatment, Pazardzhik, Bulgaria
, Georgiev D. S.
Faculty of Dental Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria
, Batselova H. M.
Department of Epidemiology and Disaster Medicine, University Hospital "St. George", Plovdiv, Bulgaria

CellR4 2020; 8: e2850
DOI: 10.32113/cellr4_20205_2850

Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

Alibashe-Ahmed M.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Berney T.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Giovannoni L.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Berishvili E.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
Ekaterine.Berishvili@unige.ch

CellR4 2017; 5 (5): e2435

Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes

Zazzeroni L.
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
luca.zazzeroni2@unibo.it
, Lanzoni G.
Diabetes Research Institute, University of Miami, Miami, FL, USA
, Pasquinelli G.
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
, Ricordi C.
Diabetes Research Institute, University of Miami, Miami, FL, USA

CellR4 2016; 4 (5): e2134

Clinical trials of mesenchymal stem cell transplantation in patients with type 1 diabetes and systemic lupus erythematosus: is it time for larger studies?

Bosi C. A.
University of Milan, Milan, Italy
carlo.bosi@studenti.unimi.it
, Lanzoni G.
Diabetes Research Institute, University of Miami, Miami, FL, USA
, Pugliese A.
Diabetes Research Institute, Departments of Medicine, Division of Diabetes, Endocrinology and Metabolism, and Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, USA